FDA announced a new funding opportunity opened Monday (March 18) for entities that develop digital health tools for use in clinical trials. The new funding stream seeks to advance digital health technologies (DHTs) that could detect disease earlier, improve outcomes for underrepresented populations or make it easier for patients to engage in remote clinical trials. Grant applications will be open from March 18 to May 20. FDA says the scope of the grant includes, but is not limited to the...